Source-faithful Form 13F holdings

Inspect one exact 13F filing without inventing company positions.

Enter a 13F-HR or 13F-HR/A accession. Issuer names, CUSIPs, manager identity, values, amounts, discretion, and voting authority remain filing observations.

Exact filing

This page

One explicit accession. No automatic amendment merge, manager canonicalization, or issuer/company resolution.

Company-centric

Current admitted ownership is separate

For reviewed current Section 16 and Schedule 13 subsets, query the canonical company ownership endpoint instead.

Open company ownership →
Clear
13F-HRReport period 2026-09-30

Aisling Capital Management LP

Manager observed CIK 0001766721Filed 2026-11-12Open filing detail →
Filing observations, not canonical company/security identities

The manager name is observed from the filing header, issuer names are reported labels, CUSIP is not promoted into canonical security identity, and the API applies no company resolution to these rows.

yesexact accession scoped
noautomatic amendment merge
nomanager canonicalized
nocompany resolution applied

Information-table rows

14 reported holdings

Showing 1–14
Values reported in thousands USD
#0

ACLARIS THERAPEUTICS INC

COM

CUSIP 00461U105
Reported value
2285233 × $1,000
Reported amount
434455 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
434455
Shared
0
None
0
#1

BICARA THERAPEUTICS INC

COM

CUSIP 055477103
Reported value
10215383 × $1,000
Reported amount
548919 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
548919
Shared
0
None
0
#2

BIOMEA FUSION INC

COM

CUSIP 09077A106
Reported value
2742847 × $1,000
Reported amount
2048757 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
2048757
Shared
0
None
0
#3

BRIDGEBIO ONCOLOGY THERAPEUT

COM NEW

CUSIP 107924102
Reported value
4137874 × $1,000
Reported amount
1018018 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
1018018
Shared
0
None
0
#4

BRIDGEBIO PHARMA INC

COM

CUSIP 10806X102
Reported value
203296404 × $1,000
Reported amount
3089611 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
3089611
Shared
0
None
0
#5

COMPASS PATHWAYS PLC

SPONSORED ADS

CUSIP 20451W101
Reported value
21550260 × $1,000
Reported amount
1732336 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
1732336
Shared
0
None
0
#6

EUPRAXIA PHARMACEUTICALS INC

COM

CUSIP 29842P105
Reported value
2957500 × $1,000
Reported amount
325000 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
325000
Shared
0
None
0
#7

MARKER THERAPEUTICS INC

COM NEW

CUSIP 57055L206
Reported value
348146 × $1,000
Reported amount
325370 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
325370
Shared
0
None
0
#8

MONTE ROSA THERAPEUTICS INC

COM

CUSIP 61225M102
Reported value
18559072 × $1,000
Reported amount
1555664 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
1555664
Shared
0
None
0
#9

ONKURE THERAPEUTICS INC

COM CL A

CUSIP 68277Q105
Reported value
241454 × $1,000
Reported amount
88607 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
88607
Shared
0
None
0
#10

SCHOLAR ROCK HLDG CORP

COM

CUSIP 80706P103
Reported value
2030938 × $1,000
Reported amount
42031 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
42031
Shared
0
None
0
#11

SYNDAX PHARMACEUTICALS INC

COM

CUSIP 87164F105
Reported value
24755953 × $1,000
Reported amount
1316806 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
1316806
Shared
0
None
0
#12

UROGEN PHARMA LTD

COM

CUSIP M96088105
Reported value
4388040 × $1,000
Reported amount
108000 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
108000
Shared
0
None
0
#13

VTV THERAPEUTICS INC

CL A NEW

CUSIP 918385204
Reported value
1812621 × $1,000
Reported amount
58775 SH
Put / call
—
Discretion
SOLE
Other manager
—
Sole
58775
Shared
0
None
0
API version sec-api-v1Authority sec-13f-institutional-holdings-v1Manager identity sec-filing-header-observationRequest-time SEC fetch no